Outcome of Omega 3 FA and Punctal Plugs on Ocular Surface Disease

• Status: Completed
• Trial end date: 2019-11-20
• Target enrollment: 0
• Participant gender: All

Summary

Ocular surface disease is a common adverse effect of systemic isotretinoin therapy.

The investigators consider that punctal plugs and Omega 3 is a good line for treatment of ocular surface disease associated with systemic isotretinoin therapy

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Benha University
• Treatments: Hyaluronic Acid; Ophthalmic Solutions

Criteria

Inclusion Criteria:

• systemic isotretinoin therapy

Exclusion Criteria:

• systemic or ocular diseases ,previous ocular surgery, corneal pathology and contact lens wearer